Updated on 6 January 2014
Aussie court holds AstraZeneca patents invalid
The patents related to the drug Crestor were challenged by Apotex, Watson Pharma and Ascent Pharma.
Wound healing ‘switch'
A*STAR scientists identified a molecular micro-RNA switch called miR-198 that controls the migration of skin cells necessary for wounds to close and heal. When skin is wounded, the manufacture of miR-198 quickly stops and the levels of miR-198 drop, switching on many wound healing processes.
Teva, Sun to pay $2.15 bn to Pfizer
Israel-based Teva Pharma and India-based Sun Pharma will pay $2.15 bn to US-based Pfizer and Japan-based Takeda to settle patent suit related to Pfizer's acid-reflux drug, Protonix (pantoprazole). This will be the first time that generic firms will pay damages for marketing a copy of an existing drug for which patents have yet to expire.
China develops world's first enterovirus vaccine
Chinese researchers have now developed the world's first ever vaccine that battles the enterovirus strain that can cause hand, foot and mouth disease.
Breakthrough in prostate cancer research
Monash University discovers that certain prostate cancer cells survive androgen withdrawal treatment and can be used as potential targets for future therapy before the cancer becomes aggressive or incurable.